Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Knockdown
100%
3′-untranslated Region (3′-UTR)
100%
Double Homeobox
100%
Facioscapulohumeral muscular Dystrophy
100%
Antisense Oligonucleotides
100%
AIDS/HIV
50%
Transcript Level
50%
Duchenne muscular Dystrophy
50%
Protein Level
50%
Genetic Disease
50%
Bioinformatics Methods
50%
Transcription Factor
50%
Negative Regulator
50%
Gain-of-function mutation
50%
Sarcopenia
50%
Aberrant Expression
50%
In Vitro Screening
50%
Myotubes
50%
Muscular Dystrophy
50%
Polyadenylation Signal
50%
Muscle Atrophy
50%
Myostatin
50%
Reading Frame
50%
Gene Silencing
50%
Transcription Termination
50%
Translation Quality
50%
Myogenesis
50%
Conditional Approval
50%
Downstream Consequences
50%
Fusion Index
50%
Downstream Genes
50%
Clinical Potential
50%
Medicine and Dentistry
Homeobox
100%
Facioscapulohumeral Muscular Dystrophy
100%
Antisense Oligonucleotide
100%
3' Untranslated Region
100%
Oligonucleotide Targeting
100%
Messenger RNA
100%
Malignant Neoplasm
50%
Duchenne Muscular Dystrophy
50%
Genetic Disorder
50%
Sarcopenia
50%
Muscular Dystrophy
50%
Downregulation
50%
Muscle Atrophy
50%
Polyadenylation
50%
Reading Frame
50%
Myostatin
50%
Transcription Factor 4
50%
RNA Processing
50%
Termination of Transcription
50%
In Vitro Screening
50%
Gain of Function Mutation
50%
Muscle Development
50%
Acquired Immune Deficiency Syndrome
50%
Myotube
50%
Gene Inactivation
50%
Biochemistry, Genetics and Molecular Biology
Antisense
100%
Oligonucleotide
100%
Homeobox
100%
3' Untranslated Region
100%
Messenger RNA
100%
Downregulation
50%
RNA Processing
50%
Genetic Disorder
50%
Myogenesis
50%
Reading Frame
50%
Myostatin
50%
Polyadenylation
50%
Transcription Factor 4
50%
Gain of Function Mutation
50%
Termination of Transcription
50%
Gene Inactivation
50%
Pharmacology, Toxicology and Pharmaceutical Science
Facioscapulohumeral Muscular Dystrophy
100%
Antisense Oligonucleotide
100%
Oligonucleotide Targeting
100%
Messenger RNA
100%
Malignant Neoplasm
50%
Genetic Disorder
50%
In Vitro Screening
50%
Muscular Dystrophy
50%
Duchenne Muscular Dystrophy
50%
Muscle Atrophy
50%
Myostatin
50%
Sarcopenia
50%
Transcription Factor 4
50%
Acquired Immune Deficiency Syndrome
50%